PRIMARY OBJECTIVE:~To demonstrate that monitoring daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse clinical events during the radiotherapy course.~SECONDARY OBJECTIVES:~I. To demonstrate the feasibility of monitoring daily step counts during a course of chemoradiotherapy in the setting of a multi-institutional trial.~II. To examine the association between baseline activity level and clinical outcomes related to treatment tolerance, quality of life, chemoradiotherapy adverse events, and physical function preservation.~III. To demonstrate associations between daily step counts and short-term hospitalization risk.~IV. To explore predictors of step count decline during chemoradiotherapy among clinical factors and radiotherapy plan parameters.~EXPLORATORY OBJECTIVES:~I. To explore patterns of care regarding adjuvant immunotherapy administration following definitive chemoradiotherapy for locally advanced non-small cell lung cancer.~II. To examine the association between baseline activity level with progression free survival and overall survival.~OUTLINE: Patients are randomized to 1 of 2 arms.~ARM I: Usual Care~ARM II: Usual Care + Continuous physical activity monitoring via a wearable device.~Patients randomized to undergo activity monitoring will use a wearable device from the time of study enrollment until four weeks after the completion of thoracic radiotherapy.
This trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of radiation treatment.